Compare Enact Holdings Inc (ACT) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enact Holdings Inc vs Twist Bioscience Corp — how do they compare? Enact Holdings Inc trades at $49.07 (market cap $6.75B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Enact Holdings Inc and Twist Bioscience Corp are close in size by market cap, and Enact Holdings Inc pays a 1.95% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| ACT | TWST | |
|---|---|---|
Market Cap | $6.75B | $7.72B |
Sector | Technology | Health |
52-Week High | $49.12 | $124.88 |
52-Week Low | $34.93 | $24.16 |
Enterprise Value | $7.05B | $7.65B |
Dividend Yield | 1.95% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enact Holdings Inc
Enact Holdings is a leading private mortgage insurance provider in the U.S. It partners with lenders to offer credit enhancement and risk management solutions, helping more borrowers achieve and maintain homeownership.
Read more on ACT →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
